Qiagen Financials
Qiagen (QGEN) reported $2.1B in revenue for fiscal year 2025, up 5.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Qiagen’s recent numbers show a margin snapback supported by steady cash conversion, not a business rebuilt by major sales growth.
In the weak-profit year, revenue barely moved while gross margin fell from62.8% to48.9% , making the earnings drop look more like a margin dislocation than a shrinking franchise. Because operating cash flow still reached$673.6M and margins rebounded the next year, the downturn appears tied more to cost mix or temporary charges than to a permanently weaker operating base.
Cash conversion stayed stronger than accounting profit: in the last two years, operating cash flow totaled
Liquidity improved sharply, with the current ratio rising to 3.9x as current liabilities fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Qiagen's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Qiagen has an operating margin of 22.3%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 76/100, reflecting efficient cost management and pricing power. This is up from 4.9% the prior year.
Qiagen's revenue grew 5.7% year-over-year to $2.1B, a solid pace of expansion. This earns a growth score of 43/100.
Qiagen has a moderate D/E ratio of 0.44. This balance of debt and equity financing earns a leverage score of 42/100.
With a current ratio of 3.90, Qiagen holds $3.90 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 85/100.
Qiagen converts 21.7% of revenue into free cash flow ($453.3M). This strong cash generation earns a score of 88/100.
Qiagen's ROE of 11.3% shows moderate profitability relative to equity, earning a score of 56/100. This is up from 2.3% the prior year.
Qiagen scores 3.70, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($9.3B) relative to total liabilities ($2.5B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Qiagen passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Qiagen generates $1.54 in operating cash flow ($654.3M OCF vs $424.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Qiagen earns $14.01 in operating income for every $1 of interest expense ($465.9M vs $33.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Qiagen generated $2.1B in revenue in fiscal year 2025. This represents an increase of 5.7% from the prior year.
Qiagen's EBITDA was $659.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 119.2% from the prior year.
Qiagen reported $424.9M in net income in fiscal year 2025. This represents an increase of 408.3% from the prior year.
Qiagen earned $1.94 per diluted share (EPS) in fiscal year 2025. This represents an increase of 424.3% from the prior year.
Cash & Balance Sheet
Qiagen generated $453.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 10.5% from the prior year.
Qiagen held $839.0M in cash against $1.7B in long-term debt as of fiscal year 2025.
Qiagen paid $0.25 per share in dividends in fiscal year 2025.
Margins & Returns
Qiagen's gross margin was 62.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 13.3 percentage points from the prior year.
Qiagen's operating margin was 22.3% in fiscal year 2025, reflecting core business profitability. This is up 17.3 percentage points from the prior year.
Qiagen's net profit margin was 20.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 16.1 percentage points from the prior year.
Qiagen's ROE was 11.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 8.9 percentage points from the prior year.
Capital Allocation
Qiagen invested $187.5M in research and development in fiscal year 2025. This represents a decrease of 3.1% from the prior year.
Qiagen spent $280.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 4.1% from the prior year.
Qiagen invested $201.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 20.3% from the prior year.
QGEN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B+5.7% | $2.0B+0.7% | $2.0B-8.2% | $2.1B-4.9% | $2.3B+20.4% | $1.9B+22.5% | $1.5B+1.6% | $1.5B+5.9% | $1.4B+5.9% | $1.3B+4.5% | $1.3B-4.7% | $1.3B+3.3% | $1.3B+3.8% | $1.3B+7.2% | $1.2B |
| Cost of Revenue | $790.5M-21.8% | $1.0B+38.2% | $731.6M-3.3% | $757.0M-5.5% | $800.8M+25.6% | $637.6M+22.3% | $521.2M+4.0% | $500.9M+1.2% | $495.0M+0.3% | $493.3M+8.6% | $454.3M-5.3% | $479.6M-1.4% | $486.5M+13.0% | $430.4M+2.5% | $419.9M |
| Gross Profit | $1.3B+34.3% | $967.4M-21.6% | $1.2B-10.9% | $1.4B-4.6% | $1.5B+17.7% | $1.2B+22.6% | $1.0B+0.4% | $1.0B+8.5% | $922.6M+9.2% | $844.7M+2.2% | $826.7M-4.5% | $865.2M+6.1% | $815.5M-1.0% | $824.0M+9.9% | $749.8M |
| R&D Expenses | $187.5M-3.1% | $193.5M-2.5% | $198.5M+4.6% | $189.9M-0.1% | $190.0M+27.4% | $149.1M-5.3% | $157.4M-2.7% | $161.9M+5.0% | $154.1M+2.8% | $149.8M+2.1% | $146.8M-10.3% | $163.7M+12.0% | $146.1M+19.3% | $122.5M-6.2% | $130.6M |
| SG&A Expenses | $125.7M+10.8% | $113.4M-4.9% | $119.3M-8.1% | $129.7M+1.3% | $128.1M+14.7% | $111.7M-0.5% | $112.3M+7.4% | $104.6M+2.4% | $102.1M | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $465.9M+376.8% | $97.7M-76.2% | $409.9M-22.9% | $531.5M-15.7% | $630.1M+63.1% | $386.4M+1578.5% | -$26.1M-109.8% | $266.6M+73.8% | $153.4M+55.2% | $98.8M-44.9% | $179.5M+11.0% | $161.7M+155.3% | $63.3M-62.7% | $169.8M+70.5% | $99.6M |
| Interest Expense | $33.3M-24.1% | $43.8M-17.9% | $53.4M-8.5% | $58.4M+7.1% | $54.5M-23.6% | $71.3M-3.9% | $74.2M+10.2% | $67.3M+35.4% | $49.7M+27.3% | $39.0M+4.3% | $37.4M-4.9% | $39.3M+27.4% | $30.9M+31.7% | $23.5M-7.5% | $25.4M |
| Income Tax | $65.4M+74.1% | $37.6M-57.6% | $88.5M-1.0% | $89.4M-21.1% | $113.2M+41.0% | $80.3M+321.0% | -$36.3M-202.7% | $35.4M-52.2% | $74.0M+416.2% | -$23.4M-465.5% | $6.4M+160.6% | $2.5M+107.7% | -$31.8M-303.4% | $15.6M+1136.4% | $1.3M |
| Net Income | $424.9M+408.3% | $83.6M-75.5% | $341.3M-19.4% | $423.2M-17.4% | $512.6M+42.7% | $359.2M+966.5% | -$41.5M-121.8% | $190.4M+371.3% | $40.4M-49.8% | $80.4M-38.2% | $130.1M+11.8% | $116.4M+68.5% | $69.1M-46.7% | $129.5M+34.8% | $96.0M |
| EPS (Diluted) | $1.94+424.3% | $0.37-75.0% | $1.48-19.6% | $1.84-16.7% | $2.21+44.4% | $1.53+950.0% | -$0.18-122.0% | $0.82+382.4% | $0.17-50.0% | $0.34-38.2% | $0.55+14.6% | $0.48+65.5% | $0.29-46.3% | $0.54+35.0% | $0.40 |
QGEN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.3B+10.4% | $5.7B-7.0% | $6.1B-2.7% | $6.3B+2.3% | $6.1B+4.7% | $5.9B+12.1% | $5.2B-8.9% | $5.7B+14.1% | $5.0B+17.0% | $4.3B+3.1% | $4.2B-6.2% | $4.5B+9.0% | $4.1B0.0% | $4.1B+9.6% | $3.7B |
| Current Assets | $2.0B+1.8% | $2.0B-8.7% | $2.1B-10.3% | $2.4B+13.5% | $2.1B+29.9% | $1.6B+3.4% | $1.6B-27.1% | $2.2B+30.8% | $1.6B+58.8% | $1.0B+7.9% | $961.4M-16.3% | $1.1B+24.7% | $920.9M-7.2% | $992.6M+33.2% | $745.4M |
| Cash & Equivalents | $839.0M+26.4% | $663.6M-0.7% | $668.1M-8.6% | $730.7M-17.0% | $880.5M+47.2% | $598.0M-4.1% | $623.6M-46.2% | $1.2B+76.2% | $657.7M+49.8% | $439.2M+51.4% | $290.0M-26.1% | $392.7M+18.9% | $330.3M-16.2% | $394.0M+78.2% | $221.1M |
| Inventory | $301.9M+8.1% | $279.3M-29.9% | $398.4M+11.3% | $358.0M+9.3% | $327.5M+12.5% | $291.2M+70.6% | $170.7M+4.8% | $162.9M+4.5% | $155.9M+14.2% | $136.6M0.0% | $136.6M+3.3% | $132.3M+3.3% | $128.1M-5.3% | $135.3M+2.3% | $132.2M |
| Accounts Receivable | $402.6M+15.3% | $349.3M-8.5% | $381.9M+18.0% | $323.8M-10.6% | $362.1M-4.8% | $380.5M-1.2% | $385.1M+9.5% | $351.6M+6.8% | $329.1M+18.3% | $278.2M+1.6% | $273.9M+3.3% | $265.2M+2.1% | $259.7M+3.6% | $250.7M+8.6% | $230.8M |
| Goodwill | $2.7B+11.3% | $2.4B-2.0% | $2.5B+5.2% | $2.4B+0.1% | $2.4B-0.6% | $2.4B+10.4% | $2.1B+1.5% | $2.1B+4.8% | $2.0B+4.5% | $1.9B+2.7% | $1.9B-0.6% | $1.9B+1.7% | $1.9B+5.4% | $1.8B+1.5% | $1.7B |
| Total Liabilities | $2.5B+17.9% | $2.1B-8.0% | $2.3B-18.2% | $2.8B-7.5% | $3.1B-0.7% | $3.1B+13.8% | $2.7B-13.3% | $3.1B+24.7% | $2.5B+46.8% | $1.7B+5.5% | $1.6B-10.6% | $1.8B+31.3% | $1.4B+0.1% | $1.4B+16.2% | $1.2B |
| Current Liabilities | $512.1M-50.9% | $1.0B-3.5% | $1.1B+10.8% | $974.5M-35.8% | $1.5B+165.2% | $572.2M-39.9% | $951.3M-2.1% | $972.2M+199.3% | $324.8M+5.3% | $308.4M+14.9% | $268.4M-37.8% | $431.6M+28.1% | $337.0M+26.3% | $266.9M-40.9% | $451.6M |
| Long-Term Debt | $1.7B+97.0% | $839.7M-8.9% | $921.8M-37.4% | $1.5B+34.5% | $1.1B-41.8% | $1.9B+32.3% | $1.4B-15.0% | $1.7B-5.0% | $1.8B+64.8% | $1.1B+1.7% | $1.0B+0.8% | $1.0B+23.2% | $845.3M-0.1% | $846.0M+89.7% | $446.0M |
| Total Equity | $3.8B+5.9% | $3.6B-6.3% | $3.8B+9.8% | $3.5B+12.0% | $3.1B+10.7% | $2.8B+10.3% | $2.5B-3.7% | $2.6B+3.7% | $2.5B-2.5% | $2.6B+1.6% | $2.6B-3.2% | $2.6B-2.4% | $2.7B0.0% | $2.7B+6.5% | $2.5B |
| Retained Earnings | $2.7B+12.3% | $2.4B-0.4% | $2.5B+13.7% | $2.2B+20.6% | $1.8B+35.4% | $1.3B+12.3% | $1.2B-14.6% | $1.4B+10.6% | $1.2B-1.2% | $1.3B+4.5% | $1.2B+7.4% | $1.1B+6.8% | $1.1B+7.0% | $985.4M+15.1% | $855.9M |
QGEN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $654.3M-2.9% | $673.6M+46.6% | $459.5M-35.8% | $715.3M+11.9% | $639.0M+39.6% | $457.8M+38.4% | $330.8M-8.0% | $359.5M+25.4% | $286.8M-16.0% | $341.6M+7.6% | $317.5M+10.3% | $288.0M+11.2% | $259.0M+5.7% | $244.9M0.0% | $244.8M |
| Capital Expenditures | $201.0M+20.3% | $167.2M+11.7% | $149.7M+15.9% | $129.2M-32.0% | $189.9M+43.0% | $132.8M+12.6% | $118.0M+7.4% | $109.8M+21.9% | $90.1M+20.9% | $74.5M-23.8% | $97.8M+12.9% | $86.6M+2.5% | $84.5M-17.2% | $102.0M+17.5% | $86.8M |
| Free Cash Flow | $453.3M-10.5% | $506.4M+63.5% | $309.7M-47.1% | $586.0M+30.5% | $449.1M+38.2% | $325.0M+52.7% | $212.9M-14.7% | $249.7M+27.0% | $196.7M-26.3% | $267.1M+21.5% | $219.7M+9.1% | $201.4M+15.4% | $174.5M+22.1% | $142.9M-9.6% | $158.0M |
| Investing Cash Flow | -$305.3M-22.5% | -$249.2M-184.3% | -$87.7M+87.9% | -$726.8M-259.0% | -$202.4M+54.3% | -$443.3M-99.4% | -$222.3M-5.2% | -$211.4M+54.5% | -$464.3M-159.3% | -$179.1M-22.5% | -$146.2M+64.1% | -$407.6M-61.9% | -$251.7M+16.3% | -$300.9M+44.3% | -$540.3M |
| Financing Cash Flow | -$179.0M+57.7% | -$422.9M+2.5% | -$433.8M-244.8% | -$125.8M+16.3% | -$150.4M-200.0% | -$50.1M+92.2% | -$639.1M-277.3% | $360.4M-6.9% | $387.2M+3751.3% | -$10.6M+95.9% | -$258.6M-234.1% | $192.8M+380.5% | -$68.8M-130.3% | $226.6M+172.9% | -$310.6M |
| Dividends Paid | $54.2M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $280.1M-4.1% | $292.1M | $0 | $0-100.0% | $100.0M+56.2% | $64.0M-14.0% | $74.5M-28.9% | $104.7M+71.7% | $61.0M | $0-100.0% | $20.8M-83.6% | $126.9M+47.5% | $86.0M+141.3% | $35.7M | $0 |
QGEN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.2%+13.3pp | 48.9%-13.9pp | 62.8%-1.9pp | 64.6%+0.2pp | 64.4%-1.5pp | 65.9%+0.1pp | 65.9%-0.8pp | 66.6%+1.6pp | 65.1%+2.0pp | 63.1%-1.4pp | 64.5%+0.2pp | 64.3%+1.7pp | 62.6%-3.1pp | 65.7%+1.6pp | 64.1% |
| Operating Margin | 22.3%+17.3pp | 4.9%-15.9pp | 20.9%-4.0pp | 24.8%-3.2pp | 28.0%+7.3pp | 20.7%+22.4pp | -1.7%-19.5pp | 17.8%+6.9pp | 10.8%+3.4pp | 7.4%-6.6pp | 14.0%+2.0pp | 12.0%+7.2pp | 4.9%-8.7pp | 13.5%+5.0pp | 8.5% |
| Net Margin | 20.3%+16.1pp | 4.2%-13.1pp | 17.4%-2.4pp | 19.8%-3.0pp | 22.8%+3.6pp | 19.2%+21.9pp | -2.7%-15.4pp | 12.7%+9.8pp | 2.9%-3.2pp | 6.0%-4.1pp | 10.2%+1.5pp | 8.6%+3.3pp | 5.3%-5.0pp | 10.3%+2.1pp | 8.2% |
| Return on Equity | 11.3%+8.9pp | 2.3%-6.6pp | 9.0%-3.3pp | 12.2%-4.3pp | 16.6%+3.7pp | 12.8%+14.5pp | -1.6%-8.9pp | 7.2%+5.6pp | 1.6%-1.5pp | 3.1%-2.0pp | 5.1%+0.7pp | 4.4%+1.9pp | 2.5%-2.2pp | 4.8%+1.0pp | 3.8% |
| Return on Assets | 6.8%+5.3pp | 1.5%-4.1pp | 5.6%-1.1pp | 6.7%-1.6pp | 8.3%+2.2pp | 6.1%+6.9pp | -0.8%-4.1pp | 3.3%+2.5pp | 0.8%-1.1pp | 1.9%-1.2pp | 3.1%+0.5pp | 2.6%+0.9pp | 1.7%-1.5pp | 3.2%+0.6pp | 2.6% |
| Current Ratio | 3.90+2.0x | 1.88-0.1x | 1.99-0.5x | 2.46+1.1x | 1.39-1.4x | 2.84+1.2x | 1.65-0.6x | 2.22-2.9x | 5.07+1.7x | 3.36-0.2x | 3.58+0.9x | 2.66-0.1x | 2.73-1.0x | 3.72+2.1x | 1.65 |
| Debt-to-Equity | 0.44+0.2x | 0.240.0x | 0.24-0.2x | 0.42+0.1x | 0.35-0.3x | 0.67+0.1x | 0.56-0.1x | 0.63-0.1x | 0.69+0.3x | 0.410.0x | 0.410.0x | 0.39+0.1x | 0.310.0x | 0.31+0.1x | 0.17 |
| FCF Margin | 21.7%-3.9pp | 25.6%+9.8pp | 15.8%-11.6pp | 27.4%+7.4pp | 20.0%+2.6pp | 17.4%+3.4pp | 14.0%-2.7pp | 16.6%+2.7pp | 13.9%-6.1pp | 20.0%+2.8pp | 17.2%+2.2pp | 15.0%+1.6pp | 13.4%+2.0pp | 11.4%-2.1pp | 13.5% |
Similar Companies
Where Qiagen Ranks
Frequently Asked Questions
What is Qiagen's annual revenue?
Qiagen (QGEN) reported $2.1B in total revenue for fiscal year 2025. This represents a 5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Qiagen's revenue growing?
Qiagen (QGEN) revenue grew by 5.7% year-over-year, from $2.0B to $2.1B in fiscal year 2025.
Is Qiagen profitable?
Yes, Qiagen (QGEN) reported a net income of $424.9M in fiscal year 2025, with a net profit margin of 20.3%.
What is Qiagen's EBITDA?
Qiagen (QGEN) had EBITDA of $659.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Qiagen have?
As of fiscal year 2025, Qiagen (QGEN) had $839.0M in cash and equivalents against $1.7B in long-term debt.
What is Qiagen's gross margin?
Qiagen (QGEN) had a gross margin of 62.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Qiagen's operating margin?
Qiagen (QGEN) had an operating margin of 22.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Qiagen's net profit margin?
Qiagen (QGEN) had a net profit margin of 20.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Qiagen pay dividends?
Yes, Qiagen (QGEN) paid $0.25 per share in dividends during fiscal year 2025.
What is Qiagen's return on equity (ROE)?
Qiagen (QGEN) has a return on equity of 11.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Qiagen's free cash flow?
Qiagen (QGEN) generated $453.3M in free cash flow during fiscal year 2025. This represents a -10.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Qiagen's operating cash flow?
Qiagen (QGEN) generated $654.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Qiagen's total assets?
Qiagen (QGEN) had $6.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Qiagen's capital expenditures?
Qiagen (QGEN) invested $201.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Qiagen spend on research and development?
Qiagen (QGEN) invested $187.5M in research and development during fiscal year 2025.
What is Qiagen's current ratio?
Qiagen (QGEN) had a current ratio of 3.90 as of fiscal year 2025, which is generally considered healthy.
What is Qiagen's debt-to-equity ratio?
Qiagen (QGEN) had a debt-to-equity ratio of 0.44 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Qiagen's return on assets (ROA)?
Qiagen (QGEN) had a return on assets of 6.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Qiagen's Altman Z-Score?
Qiagen (QGEN) has an Altman Z-Score of 3.70, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Qiagen's Piotroski F-Score?
Qiagen (QGEN) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Qiagen's earnings high quality?
Qiagen (QGEN) has an earnings quality ratio of 1.54x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Qiagen cover its interest payments?
Qiagen (QGEN) has an interest coverage ratio of 14.01x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Qiagen?
Qiagen (QGEN) scores 65 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.